By integrating serum sodium levels into the model for end-stage liver disease (MELD) score, the MELD-Na score became a better outcome predictor for HCC patients with worsening liver function compared with the CP and ALBI scores [26]. This evidence concerns the gene CP and End Stage Liver Disease.